U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649941) titled 'A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood' on June 11.
Brief Summary: The main objective of this trial is to investigate the effect of a moderate CYP 3A inducer bosentan on the pharmacokinetics of zongertinib.
Study Start Date: June 22
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Zongertinib
Zongertinib
DRUG: Bosentan
Bosentan
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Daily Digest....